Articles

Show Preview: Explore the brain and nervous system at Neuroscience 2016

After visiting Chicago last year, the Society for Neuroscience brings its annual meeting to the warmer climes of Southern California
Written byJeffrey Bouley
| 15 min read

Society for Neuroscience 46th Annual Meeting

Neuroscience 2016

November 12-16, 2016

San Diego Convention Center

Explore the brain and nervous system at Neuroscience 2016

After visiting Chicago last year, SfN brings its annual meeting to the warmer climes of Southern California

SAN DIEGO—If you haven’t already registered for the 46th Annual Meeting of the Society for Neuroscience (SfN) and made travel plans to get to and stay in San Diego this November, there’s a good chance you’re not going. But there’s always the possibility you might want to change your mind, and even if not, we at DDNews want to give you an idea of why you might want to reconsider that choice next year if your work delves into the neuroscience realm.

Plus, we want to give those who are already committed to attend an idea of what they’ll be getting for their time and money.

When asked what is different, new or expanded for Neuroscience 2016 compared to last year, SfN President Dr. Hollis Cline tells DDNews, “Every year the Society for Neuroscience seeks to grow the value of our meeting by enhancing our programming to meet the evolving needs of the field. For example, this year SfN added several more sessions designed for our clinician-scientist attendees and anyone interested in the fascinating process that leads from basic science discoveries to the clinical applications.”

Since 2005, the “Meet the Experts” series at the SfN annual meetings has provided an opportunity for students and postdoctoral researchers to engage experienced neuroscientists in an informal dialogue on a variety of topics. That tradition continues this year.

During each 75-minute session, experts describe their research techniques and accomplishments in what SfN calls “a personal context that offers participants a behind-the-scenes look at factors influencing their work.” At Neuroscience 2013, SfN began recording the live event and has made each session available online as a podcast since then.

But there is a twist this year, with the addition of a new “Meet the Clinician Expert” event that will give attendees a glimpse into the research techniques and motivating influences behind one expert clinician’s career, Cline explains.

In addition, she says, “a new series of Basic-Translational-Clinical Roundtables will feature panels of scientists discussing three areas of translational research: neuroinflammation and psychiatric disorders, medications development for cannabis use disorder and critical topics in pain therapeutics.”

These new events complement SfN’s already-established Clinical Neuroscience Lecture, which Cline notes will this year focus on “Deciphering the Dynamics of the Unconscious Brain Under General Anesthesia.”

Obviously, the SfN annual meetings serve the needs and interests of a wide variety of people in the neuroscience realm, not just those who work on diagnostics or in the discovery through clinical trials pipeline we cover at DDNews. But there is much to interest our readers at Neuroscience 2016 or any of the other SfN meetings.

“Basic science feeds the drug development pipeline and lays the foundation for every new drug that appears on the shelves of our local pharmacies,” Cline stresses. “Neuroscientists play crucial roles in every stage of drug development, from basic science research to preclinical to clinical. Thus, Neuroscience 2016 offers a multitude of events for those interested in drug development and related efforts.”

Specifically, she notes, two of SfN’s large lectures should be of interest, as they focus on new drug development to combat pain and recent progress and challenges of using immunotherapy for neurodegenerative disorders.

“In addition, I would highly recommend two of our professional development workshops. During the ‘Path to Translation for the Inspired’ event, panelists will share valuable lessons learned in translational research, from bench to bedside, and afterward NIH staff will discuss funding opportunities available to enable translational research in areas related to neuroscience. The ‘Careers in Making Medicines: Translating Basic Research Into Pharmaceutical Development’ workshop will highlight career opportunities in the pharmaceutical industry and provide perspectives from preclinical and clinical experts on how basic and innovative biology can be turned into a drug discovery program.”

Speaker selection is always an important factor in planning events like these, but even with a large number of qualified people to talk about myriad topics, one in particular stands out to Cline.

“Neuroscience research plays a key role in enhancing our knowledge of the possible causes and treatments for psychiatric diseases and disorders,” she says by way of introduction. “I have invited Dr. Shekhar Saxena, director of the Department of Mental Health and Substance Abuse at the World Health Organization, to speak about how the neuroscience and mental health fields can collaborate to take advantage of the great potential for neuroscience advances to benefit global mental health.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue